Skip to main content

Disease Activity Drives Adverse Pregnancy Outcomes in RA

Sep-13-2022

Two large RA registries have shown that pregnancy outcomes in rheumatoid arthritis (RA) patients is more related to RA disease activity rather than treatments use to control RA. 

Analysis of the Swedish Rheumatology Quality Register abd the Danish clinical quality register (DANBIO) sought to link specific to pregnancy outcomes, especially preterm birth (PTB) and small for gestational age (SGA), to RA disease activity and anti-rheumatic treatment before and during pregnancy.

Read Article

2022 New ACR Guidance on Glucocorticoid-Induced Osteoporosis (GIOP)

Sep-14-2022

The ACR has updated this guideline and includes recommendations on abaloparatide (PTHrP) and romosozumab, which are newly available since the ACR’s 2017 GIOP guideline.

It also addresses sequential therapy, which was not addressed in the past. Patients need to understand that when beginning a course of denosumab (DEN), teriparatide (PTH), abaloparatide (PTHrP), or romosozumab, they will need additional therapy after these drugs are discontinued.

Read Article

70% of Older Adults Report Joint Pain

Sep-14-2022

Dr. Beth Wallace and colleagues at the University of Michigan surveyed a national sample of older adults (50–80 yrs) and found that 70% currently report experiencing joint pain and 60% reported being told by a health care professional that they have arthritis. 

Read Article

IBD Ups Risk of Psoriatic Disease

Sep-15-2022

Findings of a new study suggest a causal effect between inflammatory bowel disease (IBD) and psoriasis (PSO) as well as psoriatic arthritis (PsA), but not vice versa.

A mendelian randomization study based on genome-wide association studies including up to 463 372 European individuals found a positive association between IBD (especially Crohn's colitis) and psoriasis and psoriatic arthritis.  The data analysis was performed from April to May 2022.

Samples included 12 882 IBD and 5621 PSO cases. Genetically predicted IBD was associated with higher risk of:

Read Article

Does Methotrexate Use Lead to Melanoma?

Sep-15-2022

A systematic review suggests that low-dose methotrexate (MTX) use is associated with an increased melanoma risk, but the absolute risk increase could be considered negligible.

Read Article

Test article (video poster)

Sep-16-2022

demo

Read Article

CD19 CAR T Cell Therapy in SLE (9.16.2022)

Sep-16-2022
The big news this week: the approval of deucravacitinib (a new class of drug?) for psoriasis; the 2022 ACR guidance on glucocorticoid-induced osteoporosis; a national poll of older adults over the age of 50 who claimed self-reported or doctor-diagnosed arthritis; and much more. Let's review these and other news, journal reports and announcements from this past week.
Read Article

Hydroxychloroquine Dosing and SLE Flares

Sep-19-2022
A cohort study examining hydroxychloroquine dosing in patients with SLE suggests that HCQ doses of 5 mg/kg per day or less, in accordance with current ophthalmology and rheumatology guidelines, was associated with a higher risk of lupus flares, including moderate or severe lupus flares.
Read Article

ACR's State-by-State Report Cards for Rheumatic Disease

Sep-19-2022

New report examines access, affordability, and activity and lifestyle factors in all 50 states and the District of Columbia, evaluating how easy it is to live with a rheumatic disease in your state. No state scored an "A" or "F", and only two states improved their 2018 grades.

Read Article

Is PMR the Next Indication for Tocilizumab?

Sep-21-2022

About half of patients with steroid-dependent polymyalgia rheumatica (PMR) were able to get off steroids altogether when they were started on tocilizumab (Actemra) infusions, which also improved disease control in most cases, a randomized phase III trial showed.

In a 24-week study, 49.0% of patients assigned to the interleukin (IL)-6 inhibitor were no longer taking prednisone at their final evaluation, compared with 19.6% of a placebo group, according to Valérie Devauchelle-Pensec, MD, PhD, of Hôpital de la Cavale Blanche in Brest, France, and colleagues.

Read Article

Yoga Fails to Benefit Knee Osteoarthritis

Sep-20-2022

The Annals of Internal Medicine has published a study showing online yoga education and an unsupervised yoga program may improve physical function did not improve knee pain after 12 weeks and 24 weeks.

The study included 212 adults with symptomatic knee osteoarthritis who were randomized to either online osteoarthritis information (control or yoga therapy (access to an unsupervised online yoga program delivered via prerecorded videos over 12 weeks).

Read Article

Clinical Profiles Seen with NXP-2 Antibodies

Sep-20-2022
A recent review of the myositis associated autoantibody NXP-2 profiles its clinical associations with dermatomyositis (DM), calcinosis, severe myositis and, in some reports, with cancer.
Read Article

USPSTF Recommends Screening for Anxiety and Depression

Sep-22-2022

The U.S. Preventive Services Task Force has recommended that general practitioners actively screen and identify anxiety and depression in all adult patients under 65 yrs.

The USPSTF was appointed by the Department of Health and Human Services, and has been working on this guideline since before the pandemic.

Read Article

Cancer Risk with Scleroderma

Sep-22-2022
Spanish Scleroderma Registry examined a large cohort of systemic sclerosis (SSc) patients showing an increased cancer risk, especially breast, lung, hematologic and colorectal cancer. The registry included 1930 patients with SSc and were compared to a matched general population to derive the standardized incidence ratios (SIRs) and independent cancer risk factors.
Read Article

ACR Questions Medicare Proposed Cuts to Critical Services Reimbursement by Cognitive Specialists

Sep-08-2022
In comments submitted to the Centers for Medicare and Medicaid Services (CMS) in response to the CY 2023 Medicare Physician Fee Schedule and Quality Payment Program proposed rule, the American College of Rheumatology applauded proposals that would provide more flexibility and improve care coordination, while raising concerns about proposed cuts to reimbursement for critical services provided by rheumatologists and other cognitive specialists.
Read Article

Rheumatology Leaders and Patient Advocates Convene on Capitol Hill

Sep-26-2022
ACR members along with rheumatology patients gathered on Capitol Hill and urged federal lawmakers to support the HELP Copays Act, Safe Step Act, and Improving Seniors’ Timely Access to Care Act.
Read Article

Immune Benefits to Sound Sleep

Sep-26-2022
The revitalizing powers of sleep are numerous but what are the consequences to inadequate sleep? A current report in the Journal of Experimental Medicine shows the connection between sleep and immune function as measured in mice and humans; specifically, a good night’s sleep promotes normal production and programming of hematopoietic stem cells. 
Read Article

Are We Overcautious With TNF Inhibitors in Pregnancy?

Sep-27-2022

What may seem like a prudent approach to treatment of inflammatory bowel disease (IBD) in pregnant women actually represents an overabundance of caution, suggested researchers who found no increased risk from tumor necrosis factor (TNF) inhibitors.

Read Article

NSAIDs Linked to Heart Failure in Diabetes Patients

Sep-27-2022

Short-term use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a first-time hospitalisation for heart failure in patients with type 2 diabetes, according to research presented at ESC Congress 2022.

Read Article

Efficacy and Safety of JAK Inhibitors in Psoriatic Disease

Sep-28-2022
There is a growing body of evidence demonstrating efficacy and safety of JAK inhibitors in patients with moderate-to-severe psoriasis and psoriatic arthritis, according to a systematic review in BMC Rheumatology.
Read Article

Uncommon Misdiagnosis of Rheumatoid Arthritis

Sep-28-2022

Using long-term patient data from the BARFOT study of early rheumatoid arthritis (RA) patients, researchers at the Karolinska Institute have shown that use of the ACR-1987 classification criteria was highly precise.

The BARFOT (Better Anti-Rheumatic PharmacOTherapy) study enrolled early RA patients. This analysis included 2543 patients with at least 4 follow-up visits after initial enrollment and assessment by rheumatologists.  Patients were assessed for diagnosis vs. misdiagnosis using the ACR-1987 classification criteria.

Read Article

2022 Lasker Award Winners

Sep-29-2022
The Lasker Foundation has announced the winners of its 2022 Lasker Awards, widely regarded as America’s top biomedical research prize since its creation more than 75 years ago. Here's a look at the award winners and their important contributions to biomedical research.
Read Article

Opioid Crisis Costs USA $1.5 Trillion

Sep-29-2022
Reuters has reported the results of a Congressional report showing the economic toll of the opioid addiction and overdose crisis on the United States reached nearly $1.5 trillion in 2020 alone and is likely to grow.
Read Article

Great and Not So Great (9.30.2022)

Sep-30-2022
This week it's the great and not-so-great on gout, chondrocalcinosis, osteoporosis and misdiagnosis. We are good at many of those things - what's not so great? Let's review the news and journal reports from the past week on RheumNow.
Read Article

Causes of Death in Lupus

Oct-03-2022
The California Lupus Surveillance Project has longitudinally followed included systemic lupus erythematosus (SLE) cases and shown that overall, the leading cause of death was cardiovascular disease (CVD), followed by rheumatic disease and hematologic/oncologic conditions.
Read Article

IL-17 Switching Works in Psoriatic Disease

Oct-03-2022
Analysis of data from a Czech nationwide registry of psoriatic patients receiving biologic or targeted therapies (BIOREP) has shown a high success rate when switching between specific IL-17 inhibitors.
Read Article

Heavy Metal Rheumatology (9.23.2022)

Sep-23-2022
Below are this week’s highlights from RheumNow, as discussed by Dr. Jack Cush. Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me or recording your suggestion using the "Ask Cush Anything" link on our website.
Read Article

Rheumatoid Arthritis Patients Need to Quit Smoking ASAP

Oct-04-2022

While it is known that smoking ups the risk of developing RA, its effect on outcomes in those with established rheumatoid arthritis (RA) is less known.  A report from an early arthritis registry shows that current smoking increases disease activity and lowers health-related quality of life.

The report from Drs. Alfredsson, Klareskog, and Hedström appears in the current issue of Arthritis Care & Research.

Read Article

Transitioning JIA to Adult Care is Problematic

Oct-04-2022

Juvenile idiopathic arthritis (JIA) may start in adolescence and extend into adulthood. This report of the Nordic experience shows that both pediatric and adulty rheumatologists need to develop "transition" practices; without such an approach considerable gaps in healthcare will befall these JIA patients. 

Their study population included 408 JIA patients with a disease onset from 1997 to 2000 and who attended an this Nordic JIA clinic. Their review disclosed 3 patterns (subgroups):

Read Article

Orthopedic surgery patients do fine without opioid painkillers

Oct-05-2022

Hamilton, ON (Oct. 4, 2022) – Patients can recover from orthopedic surgery just as well without using opioid-based painkillers, says a McMaster University and Hamilton Health Sciences (HHS) study published by the Journal of the American Medical Association (JAMA).

Study results showed that by prescribing a combination of three non-opioid painkillers to patients, researchers successfully reduced approximately tenfold the amounts of opioids consumed over a six-week post-operative period, without altering their pain levels.

Read Article
×